REQUEST A DEMO
Total
USD $0.00
Search more companies

Wuhan Healthgen Biotechnology Corp. (武汉禾元生物科技股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Wuhan Healthgen Biotechnology Corp. Profile Updated: May 26, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Wuhan Healthgen Biotechnology Corp. (武汉禾元生物科技股份有限公司) is an enterprise in China, with the main office in Wuhan. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on November 16, 2006. In Q12026, the company reported a net sales revenue increase of 132.39%. Its’ total assets recorded a growth of 199.93%.

Headquarters
No. 666, High-tech Avenue, East Lake Development Zone, Wuhan City, Hubei Province
Wuhan; Hubei; Postal Code: 430206

Contact Details: Purchase the Wuhan Healthgen Biotechnology Corp. (武汉禾元生物科技股份有限公司) report to view the information.

Basic Information
Outstanding Shares:
Purchase the Wuhan Healthgen Biotechnology Corp. (武汉禾元生物科技股份有限公司) report to view the information.
Registered Capital:
Purchase the Wuhan Healthgen Biotechnology Corp. (武汉禾元生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Wuhan Healthgen Biotechnology Corp. (武汉禾元生物科技股份有限公司) report to view the information.
Incorporation Date:
November 16, 2006
Ownership Details
Purchase this report to view the information.
11.27%
Purchase this report to view the information.
5.62%
Purchase this report to view the information.
5.6%
Purchase this report to view the information.
4.84%
Purchase this report to view the information.
4.28%
Company Performance
Financial values in the chart are available after Wuhan Healthgen Biotechnology Corp. (武汉禾元生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
132.39%
Total Operating Revenue
235.7%
Total Assets
199.93%
Total Equity
413.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?